Harsh Kishore
YOU?
Author Swipe
View article: A Multicentre Double Blind, Placebo Controlled Randomized Trial to Evaluate the Safety and Efficacy of Bovine Colostrum in the Treatment of Severe Alcoholic Hepatitis (SAH).
A Multicentre Double Blind, Placebo Controlled Randomized Trial to Evaluate the Safety and Efficacy of Bovine Colostrum in the Treatment of Severe Alcoholic Hepatitis (SAH). Open
Background Alcoholic Hepatitis (AH) in patients of 2 contemporary Randomized Controlled Trials in India was extremely severe: Maddrey’s Discriminant Function (mDF) [score of 77.4–84 ; MELD of 26–27.5]. The survival rate was very low: 22–30…
Outpatient Attendance in COVID Pandemic Lockdown: An Observational Study Open
Objectives: The objectives of this study were to analyze the profile of outpatient department (OPD) attendance of a tertiary care hospital during pre- and post-pandemic lockdown period. Materials and Methods: All consecutive patients prese…
View article: Early feeding after esophageal variceal band ligation in cirrhotics is safe: Randomized controlled trial
Early feeding after esophageal variceal band ligation in cirrhotics is safe: Randomized controlled trial Open
Background and Aim Oral feeding following variceal ligation in cirrhotics is usually delayed due to fear of rebleeding. Solid diet is usually further delayed (until 72 h) despite lack of evidence. We aimed to compare the impact of early ve…
View article: Reply
Reply Open
Potential conflict of interest: Nothing to report. Author names in bold designate shared co‐first authorship. We thank Dr. Sahaj Rathi and his colleague for their interest in our work. In our study,1 the grade of hepatic encephalopathy (HE…
View article: L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy
L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy Open
High‐quality data on the efficacy of L‐ornithine L‐aspartate (LOLA) in patients with cirrhosis and bouts of overt hepatic encephalopathy (OHE) are missing. We evaluated the efficacy of intravenous LOLA in the reversal of bouts of OHE in pa…
Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat? Open
Of the patients who became MHE negative after short-term (3 months) treatment with rifaximin/lactulose, almost 50% had a relapse of MHE at 6 months follow-up.